{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "ANA.AQ",
  "generated_at": "2026-01-02T22:00:39.984503Z",
  "top_card": {
    "ticker": "ANA.AQ",
    "company_name": "Ananda Pharma Plc",
    "sector": "Healthcare",
    "market_cap_gbp": 4256155,
    "days_active": 0,
    "apex_score_100": 64,
    "confidence_score_100": 60,
    "ai_final_score_25": null,
    "ai_strength": null,
    "timing_regime": "EARLY_BUILD",
    "action": "WATCH",
    "thesis_one_liner": "WATCH - EARLY_BUILD timing with 64/100 opportunity score"
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 64/100 indicates strong opportunity quality",
      "Timing regime: EARLY_BUILD",
      "Historical profile: 1 rallies, 277% best run"
    ],
    "main_risk": "Confidence 60/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "latest": [
        {
          "title": "US Cannabis Rescheduling",
          "date": "2026-01-02T15:58:22.071892Z"
        },
        {
          "title": "US Cannabis Rescheduling",
          "date": "2026-01-02T15:58:22.071944Z"
        },
        {
          "title": "Result of General Meeting",
          "date": "2026-01-02T15:58:22.071974Z"
        },
        {
          "title": "Redemption of Unsecured CLNs and Director Dealing",
          "date": "2026-01-02T15:58:22.072001Z"
        },
        {
          "title": "CIPN Ethics Approval",
          "date": "2026-01-02T15:58:22.072028Z"
        }
      ],
      "themes": [
        "regulatory"
      ]
    },
    "social": {
      "has_data": false,
      "buzz_level": null,
      "post_count": null,
      "sentiment_breakdown": {
        "positive": null,
        "neutral": null,
        "negative": null
      }
    },
    "trends": {
      "has_data": false,
      "current_interest": null,
      "momentum_score": null,
      "trend_direction": null,
      "intelligence_signal": null
    },
    "volatility": {
      "atr_normalized": null,
      "stddev_20d": null
    },
    "risk_flags": {
      "split_risk_level": null,
      "halt_risk": null,
      "penny_stock_risk": null
    }
  },
  "ai_insights": {
    "available": false,
    "reason": "LLM module not loaded or analysis failed"
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +18 (AI_Technical_Score=14.0/20)",
      "Drawdown reversion potential: +19 (Drawdown_Pct=94.3%)",
      "Volume confirmation: +10 (Relative_Volume=2.3)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +12 (best_rally_pct=277%)"
    ],
    "technical_score": {
      "points": 18,
      "ai_score": 14.0,
      "reason": "AI Technical Score 14.0/20 translates to 18/25 points"
    },
    "drawdown_score": {
      "points": 19,
      "drawdown_pct": 94.32,
      "reason": "Drawdown of 94.3% gives 19/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 2.28,
      "reason": "Relative volume 2.28x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 12,
      "best_rally_pct": 276.67,
      "reason": "Best rally of 277% gives 12/20 points"
    },
    "penalties": {
      "total": 0,
      "items": []
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Early stage positioning offers best R:R if catalysts appear",
        "tag": "MED",
        "evidence": [
          "timing_regime=EARLY_BUILD",
          "current_return_pct=83.3%"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Triangulation not loaded (RNS/social/trends missing)",
        "tag": "HIGH",
        "evidence": [
          "analysis_mode=HISTORICAL_ONLY",
          "confidence_capped_at_65"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Watch / Starter",
      "action": "Wait for base + catalyst confirmation; starter position only",
      "sizing": "0-1% until CONFIRMED",
      "risk": "Invalidation = breaks recent lows / dilution / suspension",
      "profit_taking": "Scale out 25% at +15%, 25% at +50%, runner above"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "EARLY_BUILD",
    "run_multiple": 0.3,
    "current_run_pct": 83.33,
    "avg_historical_run_pct": 276.67
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows EARLY_BUILD timing with 64/100 APEX score. Historical data shows 1 rallies averaging 277% upside. Current position: +83.3%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Early regime often offers best risk/reward"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Early accumulation phase. Watch for confirmation before committing size.",
    "confidence_explained": "Confidence 60/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": false,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": false
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}